Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs Navio MD

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Navio MD head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 74 · Grade C

Navio MD

Visit Navio MD Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 77 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make Navio MD a bad call — it's best for readers comparing advertised compounded and brand routes who will obtain the complete payment and commercial terms before starting. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
48
Supply Reliability
95
80
Transparency
90
88
Access Breadth
93
90
Clinical Oversight
92
87
Track Record
88
82
CoreAge RxBrief Score 94 · 77Navio MD

Price, coverage & the tracker

CoreAge RxNavio MD
Brief Score94/100 (A)77/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

Confirm current medication quote

Earlier starting brand quote: $345/mo. Current semaglutide availability and full price require confirmation.

Full price details

Current medication quote unknown; earlier observed from $345/month for starting-dose brand semaglutide

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

Confirm full upfront quote

Compounded tirzepatide advertised from $189/mo; full upfront charge, term and renewal remain unclear.

Full price details

Compounded tirzepatide offered. Current complete quote unknown; earlier observed from $189/month for starting-dose compounded tirzepatide

CoverageUS only; restrictions by state, confirmed at intakeMedication-specific state availability requires confirmation
Brand-name accessNot confirmedYes
Oral / sublingualInjection onlyInjection only
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

Navio MD: Current complete prices remain unconfirmed. The $189 compounded tirzepatide and $445 Zepbound starting offers require the selected plan, upfront charge and renewal terms to be clarified.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.